DUBLIN, 30-May-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018, in Rancho Palos Verdes, Calif. Omar Ishrak, Medtronic … Read the full press release
Workshop with regulators from EU, Japan and US open for registration LONDON, 28-May-2018 — /EuropaWire/ — The European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and the United States’ Food and Drug Administration (FDA) are co-organising a workshop to discuss the development … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged antibiotics for children, antimicrobial resistance, EMA, FDA, PMDA, workshop
European Commission’s (EC) approval based on comprehensive data package confirming that Zessly® matches safety, efficacy and quality of reference medicine Biosimilars such as Zessly enable earlier patient access to important medicines and positively impact healthcare systems Zessly is the third EC … Read the full press release
Posted in European Union, Germany, Healthcare, Pharma & Biotech
Tagged Europe, European Commission, infliximab, Novartis, Richard Francis, Sandoz, Zessly®
Vevey, Switzerland, 24-May-2018 — /EuropaWire/ — Nestlé has today announced changes that further strengthen its research and development operations, the largest of any food company worldwide. Nestlé will bring together its two scientific discovery units, the Nestlé Research Center and the … Read the full press release
LIVERPOOL, 24-May-2018 — /EuropaWire/ — Researchers from the University of Liverpool have been awarded a £73k grant from Epilepsy Research UK to help identify brain imaging biomarkers for drug treatment response in epilepsy. Dr Simon Keller, from the University’s Institute Of Translational Medicine, … Read the full press release
Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled asthma, irrespective of minimum baseline eosinophil levels or other biomarkers of Type 2 inflammation Greater … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged asthma, corticosteroids, Dupixent, New England Journal of Medicine, Sanofi
NOTTINGHAM, 21-May-2018 — /EuropaWire/ — Researchers have discovered new natural compounds in a fig plant species native to Malaysia that could lead to improved treatment for resistant hypertension. Dr Kuan Hon Lim and his team from the University of Nottingham Malaysia have isolated a new class of natural compounds from a local fig plant species that induce vasodilation in aorta tissue, … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged aorta blood vessels, chromatography techniques, Dr Kuan Hon Lim, fig plant, High blood pressure, hypertension, natural compounds, resistant hypertension, treatment for resistant hypertension, University of Nottingham Malaysia, vasodilation
Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018. Data presented … Read the full press release
Two old drugs for combatting urinary tract infections are being prescribed once more in an attempt to protect newer antibiotics from bacterial resistance, and thus preserve their effectiveness. Only one of these drugs from yesteryear appears to be as effective … Read the full press release
With millimetre precision, certain tumours can be irradiated at the Paul Scherrer Institute PSI using protons – that is, positively charged elementary particles. PSI is the one place in Switzerland where this especially protective and precise option for radiation therapy … Read the full press release
SOPHIA ANTIPOLIS, 15-May-2018 — /EuropaWire/ — A European Society of Cardiology (ESC) consensus statement on inflammation in atherosclerosis is published today in the European Journal of Preventive Cardiology. (1) Written by the ESC Working Group on Atherosclerosis and Vascular Biology, the document … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged anti-inflammatory drugs, Atherosclerosis, cardiovascular, cholesterol, Dr José Tuñón, ESC, European Journal of Preventive Cardiology, European Society of Cardiology, inflammation in atherosclerosis, Pharmacotherapy, PhysiologyPharmacology, rehabilitation, Sports CardiologyVascular Biology, statins
Holzkirchen, Germany, 04-May-2018 — /EuropaWire/ — Sandoz, a Novartis division, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for its proposed biosimilar rituximab. Sandoz stands behind … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged Biologics Licensing Application, Biosimilar, medicine, Novartis, rituximab, Sandoz, US FDA
Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved for two distinct indications – in non-Hodgkin … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged CAR-T, FDA, Kymriah, leukemia, Liz Barrett, lymphoma, Novartis, oncology, Stephen J. Schuster MD, tisagenlecleucel
Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release
Posted in Business, Germany, Healthcare, Law, Pharma & Biotech, Science, Technology
Tagged Chinese Patent Office, CRISPR technology, eukaryotic cells, eukaryotic_cells, genome, genomic-integration method, Merck, patent, science, Udit Batra
PARIS, 25-Apr-2018 — /EuropaWire/ — Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post … Read the full press release
Posted in France, Healthcare, Management, Pharma & Biotech
Tagged appointment, biopharmaceutical, Elias Zerhouni M.D., John C. Reed M.D. Ph.D., leadership, Management, Sanofi
Phenion: An innovative testing system for skin ageing research Düsseldorf, Germany, 24-Apr-2018 — /EuropaWire/ — The Phenion® Full Thickness Skin Model developed by Henkel scientists is e.g. known, for its application in the “3D Skin Comet assay”. This validated method allows the … Read the full press release
Researchers at Delft University of Technology, in collaboration with colleagues at the Autonomous University of Madrid, have created an artificial DNA blueprint for the replication of DNA in a cell-like structure. Creating such a complex biological module is an important … Read the full press release
Posted in Education, Netherlands, Pharma & Biotech, Science, Technology
Tagged artificial DNA blueprint, Christophe Danelon, DNA, DNA_replication, liposome, Pauline van Nies, proteins, RNA, synthetic_cell, TU Delft
WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS – WACKER BIOTECH’S OVERALL CAPACITY DOUBLES AS A RESULT SYNCO’S EXPERTISE IN MANUFACTURING LIVE MICROBIAL PRODUCTS AND IN FILLING FINISHED … Read the full press release
Critical role appointed as part of ongoing activities to strengthen and accelerate the Pharmaceuticals pipeline LONDON, 20-Apr-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) today announced the appointment of Kevin Sin as Senior Vice President and Head of Worldwide Business Development for … Read the full press release
Posted in Business, Pharma & Biotech, United Kingdom
Tagged appointment, Dr. Hal Barron, GSK, HR, Kevin Sin, leadership, Management, pharmaceuticals
LONDON, 20-Apr-2018 — /EuropaWire/ — Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?